Olcegepant Explained

Olcegepant (INN,[1] code name BIBN-4096BS) is a calcitonin gene-related peptide receptor antagonist being studied as a potential treatment for migraines.[2]

A 2013 meta-analysis found olcegepant and telcagepant were effective and safe compared to placebo.[3]

See also

Notes and References

  1. Web site: International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names: List 48 . World Health Organization . 20 March 2017 . 256–7.
  2. Tfelt-Hansen P, Olesen J . Possible site of action of CGRP antagonists in migraine . Cephalalgia . 31 . 6 . 748–50 . April 2011 . 21383046 . 10.1177/0333102411398403 . 22049557 . free .
  3. Yao G, Yu T, Han X, Mao X, Li B . Therapeutic effects and safety of olcegepant and telcagepant for migraine: A meta-analysis . Neural Regeneration Research . 8 . 10 . 938–47 . April 2013 . 25206386 . 4145922 . 10.3969/j.issn.1673-5374.2013.10.009 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Olcegepant".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.